These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 23995698
1. Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology). Mustea A, Koensgen D, Belau A, Sehouli J, Lichtenegger W, Schneidewind L, Sommer H, Markmann S, Scharf JP, Ehmke M, Ledwon P, Braicu I, Zygmunt M, Koehler G. Cancer Chemother Pharmacol; 2013 Nov; 72(5):975-83. PubMed ID: 23995698 [Abstract] [Full Text] [Related]
2. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL. Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596 [Abstract] [Full Text] [Related]
3. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach. Lupe K, Kwon J, D'Souza D, Gawlik C, Stitt L, Whiston F, Nascu P, Wong E, Carey MS. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):110-6. PubMed ID: 17084542 [Abstract] [Full Text] [Related]
4. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial. de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Kitchener HC, Nijman HW, Kruitwagen RF, Nout RA, Verhoeven-Adema KW, Smit VT, Putter H, Creutzberg CL, PORTEC study group. Lancet Oncol; 2016 Aug 01; 17(8):1114-1126. PubMed ID: 27397040 [Abstract] [Full Text] [Related]
5. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials. Marsland TA, Garfield DH, Khan MM, Look RM, Boehm KA, Asmar L. Lung Cancer; 2005 Jan 01; 47(1):111-20. PubMed ID: 15603861 [Abstract] [Full Text] [Related]
6. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S. Gynecol Oncol; 2005 Jan 01; 96(1):198-203. PubMed ID: 15589601 [Abstract] [Full Text] [Related]
7. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer. Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C, Abu-Rustum NR, Barakat RR, Alektiar KM. Gynecol Oncol; 2012 Nov 01; 127(2):321-5. PubMed ID: 22850412 [Abstract] [Full Text] [Related]
8. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study. Frigerio L, Mangili G, Aletti G, Carnelli M, Garavaglia E, Beatrice S, Ferrari A. Gynecol Oncol; 2001 Apr 01; 81(1):53-7. PubMed ID: 11277649 [Abstract] [Full Text] [Related]
9. Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors. Landrum LM, Nugent EK, Zuna RE, Syzek E, Mannel RS, Moore KN, Walker JL, McMeekin DS. Gynecol Oncol; 2014 Jan 01; 132(1):50-4. PubMed ID: 24219982 [Abstract] [Full Text] [Related]
10. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer. Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM. Gynecol Oncol; 2013 Sep 01; 130(3):436-40. PubMed ID: 23800696 [Abstract] [Full Text] [Related]
11. Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncology. Oskay-Ozcelik G, Chekerov R, Sommer H, Keil E, Einenkel J, Pfisterer J, Lorenz-Schlüter C, Lichtenegger W, Camara O, Sehouli J. Gynecol Oncol; 2010 Mar 01; 116(3):317-22. PubMed ID: 19959213 [Abstract] [Full Text] [Related]
12. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913 [Abstract] [Full Text] [Related]
13. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL, PORTEC study group. Lancet Oncol; 2018 Mar 01; 19(3):295-309. PubMed ID: 29449189 [Abstract] [Full Text] [Related]
14. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma. Lu SM, Chang-Halpenny C, Hwang-Graziano J. Gynecol Oncol; 2015 Apr 01; 137(1):28-33. PubMed ID: 25666606 [Abstract] [Full Text] [Related]
15. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712. Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712. J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656 [Abstract] [Full Text] [Related]
16. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial. Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A. Lung Cancer; 2007 Nov 20; 58(2):238-45. PubMed ID: 17658655 [Abstract] [Full Text] [Related]
18. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma. Jutzi L, Hoskins P, Lim P, Aquino-Parsons C, Tinker A, Kwon JS. Gynecol Oncol; 2013 Dec 20; 131(3):581-5. PubMed ID: 24055614 [Abstract] [Full Text] [Related]
19. A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer. Scribner DR, Puls LE, Gold MA. Gynecol Oncol; 2012 May 20; 125(2):388-93. PubMed ID: 22330696 [Abstract] [Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related] Page: [Next] [New Search]